Amarin Corp Plcuk (AMRN) Other Operating Expenses (2022 - 2026)
Amarin Corp Plcuk (AMRN) posted quarterly Other Operating Expenses of $3.1 million for Q1 2026, down 89.92% YoY from $31.2 million in Q1 2025, and up 105.01% sequentially from -$62.8 million in Q4 2025.
Amarin Corp Plcuk (AMRN) Other Operating Expenses (2022 - 2026) Analysis & Trends
Amarin Corp Plcuk has disclosed Other Operating Expenses across 5 years of filings, most recently posting $3.1 million for Q1 2026.
- In Q1 2026, Other Operating Expenses fell 89.92% year-over-year to $3.1 million; the TTM figure through Mar 2026 stood at -$46.0 million (down 326.74% YoY), while the FY2024 annual figure was $12.6 million, down 2.75% from the prior year.
- Other Operating Expenses improved to $3.1 million in Q1 2026, from -$62.8 million in the prior quarter.
- Over the last five years, Other Operating Expenses for AMRN reached as high as $31.2 million in Q1 2025 and fell as low as -$74.2 million in Q4 2024.
- The 5-year median for Other Operating Expenses is $7.9 million (2022), against an average of -$3.1 million.
- Annual changes were most pronounced in 2024 — Other Operating Expenses tumbled 673.4% — and 2025, when it soared 336.73%.
- A 5-year view of Other Operating Expenses shows it stood at $12.6 million in 2022, then grew by 2.4% to $12.9 million in 2023, then plunged by 673.4% to -$74.2 million in 2024, then climbed by 15.47% to -$62.8 million in 2025, then surged by 105.01% to $3.1 million in 2026.
- According to Business Quant data, Other Operating Expenses over the past three periods registered $3.1 million, -$62.8 million, and $13.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - |
| 10 | Amarin Corp Plcuk | 5.17 Bn | 5.00 Bn | 17.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.14 Mn |
| Dec 31, 2025 | -62.76 Mn |
| Sep 30, 2025 | 13.60 Mn |
| Mar 31, 2025 | 31.20 Mn |
| Dec 31, 2024 | -74.25 Mn |
| Sep 30, 2024 | 3.12 Mn |
| Jun 30, 2024 | 29.16 Mn |
| Dec 31, 2023 | 12.95 Mn |
| Dec 31, 2022 | 12.65 Mn |
| Jun 30, 2022 | 13,000.00 |